Trials / Conditions / BRCA-Mutated Ovarian Carcinoma
BRCA-Mutated Ovarian Carcinoma
3 registered clinical trials studyying BRCA-Mutated Ovarian Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors NCT06065059 | Tango Therapeutics, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cance NCT03943173 | M.D. Anderson Cancer Center | EARLY_Phase 1 |
| Active Not Recruiting | Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome NCT04009148 | NYU Langone Health | — |